Cargando…
Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma
Lung adenocarcinoma (LUAD), the most common histological type of non-small cell lung cancer, is one of the most malignant and deadly diseases. Current treatments for advanced LUAD patients are far from ideal and require further improvements. Here, we utilized a systematic integrative analysis of LUA...
Autores principales: | Liu, Shu-Hsuan, Hsu, Kai-Wen, Lai, Yo-Liang, Lin, Yu-Feng, Chen, Fang-Hsin, Peng, Pei-Hwa, Lin, Li-Jie, Wu, Heng-Hsiung, Li, Chia-Yang, Wang, Shu-Chi, Wu, Min-Zu, Sher, Yuh-Pyng, Cheng, Wei-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181588/ https://www.ncbi.nlm.nih.gov/pubmed/34141460 http://dx.doi.org/10.1016/j.omtn.2021.04.020 |
Ejemplares similares
-
Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma
por: Liu, Chia-Hsin, et al.
Publicado: (2022) -
Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
por: Yang, Fengming, et al.
Publicado: (2017) -
The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015) -
Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach
por: Qi, Yumei, et al.
Publicado: (2020) -
Generation of MiRNA sponge constructs targeting multiple MiRNAs
por: Jie, Junjin, et al.
Publicado: (2022)